These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 36039653)
1. An inflammation-targeted nanoparticle with bacteria forced release of polymyxin B for pneumonia therapy. Zhang P; Ouyang Q; Zhai T; Sun J; Wu J; Qin F; Zhang N; Yue S; Yang X; Zhang H; Hou Y; Deng L; Wang F; Zhan Q; Yu Q; Qin M; Gan Z Nanoscale; 2022 Oct; 14(41):15291-15304. PubMed ID: 36039653 [TBL] [Abstract][Full Text] [Related]
2. Cooperative action of SP-A and its trimeric recombinant fragment with polymyxins against Gram-negative respiratory bacteria. Coya JM; Fraile-Ágreda V; de Tapia L; García-Fojeda B; Sáenz A; Bengoechea JA; Kronqvist N; Johansson J; Casals C Front Immunol; 2022; 13():927017. PubMed ID: 36159837 [TBL] [Abstract][Full Text] [Related]
3. A novel decoy strategy for polymyxin resistance in Park J; Kim M; Shin B; Kang M; Yang J; Lee TK; Park W Elife; 2021 Jun; 10():. PubMed ID: 34180396 [TBL] [Abstract][Full Text] [Related]
4. Binding interactions of bacterial lipopolysaccharides to polymyxin B in an amphiphilic carrier 'sodium deoxycholate sulfate'. Madhumanchi S; Suedee R; Nakpheng T; Tinpun K; Temboot P; Srichana T Colloids Surf B Biointerfaces; 2019 Oct; 182():110374. PubMed ID: 31330430 [TBL] [Abstract][Full Text] [Related]
5. Polymyxin B-Polysaccharide Polyion Nanocomplex with Improved Biocompatibility and Unaffected Antibacterial Activity for Acute Lung Infection Management. Chai M; Gao Y; Liu J; Deng Y; Hu D; Jin Q; Ji J Adv Healthc Mater; 2020 Feb; 9(3):e1901542. PubMed ID: 31898875 [TBL] [Abstract][Full Text] [Related]
6. Thermodynamic analysis of the lipopolysaccharide-dependent resistance of gram-negative bacteria against polymyxin B. Howe J; Andrä J; Conde R; Iriarte M; Garidel P; Koch MH; Gutsmann T; Moriyón I; Brandenburg K Biophys J; 2007 Apr; 92(8):2796-805. PubMed ID: 17237210 [TBL] [Abstract][Full Text] [Related]
7. Effect of sodium deoxycholate sulfate on outer membrane permeability and neutralization of bacterial lipopolysaccharides by polymyxin B formulations. Madhumanchi S; Suedee R; Kaewpiboon S; Srichana T; Khalil R; Ul-Haq Z Int J Pharm; 2020 May; 581():119265. PubMed ID: 32217155 [TBL] [Abstract][Full Text] [Related]
8. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide. Tsubery H; Ofek I; Cohen S; Fridkin M Biochemistry; 2000 Oct; 39(39):11837-44. PubMed ID: 11009595 [TBL] [Abstract][Full Text] [Related]
9. Outcome of intravenous and inhaled polymyxin B treatment in patients with multidrug-resistant gram-negative bacterial pneumonia. Ding P; Li H; Nan Y; Liu C; Wang G; Cai H; Yu W Int J Antimicrob Agents; 2024 Oct; 64(4):107293. PubMed ID: 39094752 [TBL] [Abstract][Full Text] [Related]
10. Characterizing the effect of polymyxin B antibiotics to lipopolysaccharide on Escherichia coli surface using atomic force microscopy. Oh YJ; Plochberger B; Rechberger M; Hinterdorfer P J Mol Recognit; 2017 Jun; 30(6):. PubMed ID: 28054415 [TBL] [Abstract][Full Text] [Related]
11. [Comparative study of binding power of polymyxin B and its simulating peptide to lipopolysaccharides lipoid A]. Zhu ZX; Li WP; Zhang LY; Gong XY Zhonghua Shao Shang Za Zhi; 2004 Aug; 20(4):232-4. PubMed ID: 15447826 [TBL] [Abstract][Full Text] [Related]
12. Polymyxin-based fluorescent probes to combat Gram-negative antimicrobial resistance. Han X; Cui AL; Yang HX; Wu L; Wei R; Liu Q; Li ZR; Hu HY Talanta; 2023 Aug; 260():124576. PubMed ID: 37148689 [TBL] [Abstract][Full Text] [Related]
13. Interactions between polymyxin B and various bacterial membrane mimics: A molecular dynamics study. Sun Y; Deng Z; Jiang X; Yuan B; Yang K Colloids Surf B Biointerfaces; 2022 Mar; 211():112288. PubMed ID: 34942463 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity and cellular toxicity of nanoparticle-polymyxin B conjugates. Park S; Chibli H; Wong J; Nadeau JL Nanotechnology; 2011 May; 22(18):185101. PubMed ID: 21415471 [TBL] [Abstract][Full Text] [Related]
15. Outer Membrane Interaction Kinetics of New Polymyxin B Analogs in Gram-Negative Bacilli. Akhoundsadegh N; Belanger CR; Hancock REW Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332075 [TBL] [Abstract][Full Text] [Related]
16. Liquid crystalline bacterial outer membranes are critical for antibiotic susceptibility. Paracini N; Clifton LA; Skoda MWA; Lakey JH Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7587-E7594. PubMed ID: 30037998 [TBL] [Abstract][Full Text] [Related]
17. Polymyxin B induces lysis of marine pseudoalteromonads. Krupovic M; Daugelavicius R; Bamford DH Antimicrob Agents Chemother; 2007 Nov; 51(11):3908-14. PubMed ID: 17709471 [TBL] [Abstract][Full Text] [Related]
18. N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity. Tsubery H; Ofek I; Cohen S; Fridkin M Peptides; 2001 Oct; 22(10):1675-81. PubMed ID: 11587796 [TBL] [Abstract][Full Text] [Related]
19. Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A. Srimal S; Surolia N; Balasubramanian S; Surolia A Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):679-86. PubMed ID: 8615847 [TBL] [Abstract][Full Text] [Related]
20. Polymyxin B-Modified Fosfomycin Liposomes Target Gram-Negative Bacteria and Exert Synergistic Antibacterial Effect. Zhu R; Yin Z; Liu N; Wang Z; Zhang H; Li J; Shen L; Zheng A ACS Omega; 2023 Dec; 8(48):45914-45923. PubMed ID: 38075817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]